IgG IV plus prednisone versus high-dose dexamethasone for ITP
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This Phase 3 study compares two ways of treating immune thrombocytopenia (ITP) to raise blood platelet counts and reduce bleeding. It tests whether IgG given through a vein plus prednisone works better (or safer) than high-dose dexamethasone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old
- You have ITP and you have a platelet count of 20 or less
- You have skin and/or mouth/nose bleeding symptoms
- You are covered by a social security health plan and can sign consent
- You must not have certain serious bleeding, infection, or medication history problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding teriflunomide to high-dose dexamethasone helps adults newly diagnosed with immune thrombocytopenia (ITP) who have low platelets or bleeding. It aims to find a safer, more effective way to raise platelet counts.
This trial tests an IV medicine called V-IMMUNE® for people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The study aims to see if V-IMMUNE® can safely raise platelet counts in both children and adults.
This trial tests how many cycles of high-dose dexamethasone (a steroid) work best for adults newly diagnosed with ITP, a condition that causes low platelets and bruising or bleeding. The goal is to find the right dose schedule to safely raise platelet counts.
This trial compares two treatments for pregnant women with ITP (immune thrombocytopenia) and low platelet counts. It tests whether adding IVIg (immune globulin) to standard prednisone (steroid) therapy is more effective than prednisone alone.
This trial studies a short, high-dose steroid plan (prednisone plus dexamethasone) to treat immune thrombocytopenia (ITP) in children and raise low platelet counts. It may help reduce bleeding risk while using an approach tested in children soon after diagnosis.
This trial tests a combination of upadacitinib (a pill that calms the immune system) and high-dose dexamethasone (a steroid) as the first treatment for adults with newly diagnosed immune thrombocytopenia (ITP). It aims to see if this mix can safely raise platelet counts better than steroids alone.
Hear when a new Immune Thrombocytopenia (ITP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.